Product Images Venlafaxine Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Venlafaxine Hydrochloride NDC 68071-3886 by Nucare Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
pdp - 68071 3886 3
This is a medication label for Venlafaxine Hydrochloride in 75mg extended-release capsules. It provides information such as the NDC number, lot number, expiration date, and serial number. It contains a warning to keep the medication out of reach of children and store it at a controlled temperature of 68-77°F. This description can be useful for understanding the dosage and handling instructions for this medication.*
figure - venlafaxine fig1
figure - venlafaxine fig2
This text seems to list various drugs along with their PK fold change and 90% CI values. The drugs mentioned include Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, and Lithium. The values likely represent the change relative to the reference value for each drug.*
figure - venlafaxine fig3
This list provides information on drug interactions involving various substances such as Ethanol, Aprazolam, Indinavir, Metoprolal, Risperidone, Haloperidol, Caffine, Tolbutamide, and Lithium. It also includes analytes detailing the presence of these substances in different concentrations. Additionally, the list mentions PK parameters like Cmax and AU, as well as Fold Change and 90% confidence interval values.*
Chemical Structure - venlafaxine str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
